Evidence map›Paper›PMID 41703050›Full record

ArticleNature genetics2026

GGC repeat expansions within new open reading frames are translated into toxic polyglycine proteins in oculopharyngodistal myopathy.

Manon Boivin, Jiaxi Yu, Nobuyuki Eura, Léa Schmitt, David Pietri, Erwan Grandgirard, Patrice Goetz-Reiner, Damien Plassard, Chadia Nahy, Anne Maglott and 15 more

Abstract read
In one paragraph

Article in Nature genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Structural Polymorphism of polyG Inclusions Revealed by In Situ Cryo-Electron Tomography.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. CGG Repeat Expansion in GIPC1 is Associated with Childhood-Onset Hereditary Ataxia.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Manon Boivin *Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France. boivinm@igbmc.fr.ORCID http://orcid.org/0000-0003-4055-9733
Jiaxi Yu *Department of Neurology, Peking University First Hospital, Beijing, China.
Nobuyuki EuraDepartment of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.
Léa SchmittInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.
David PietriInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.
Erwan GrandgirardInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.
Patrice Goetz-ReinerInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.
Damien PlassardInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.ORCID http://orcid.org/0000-0001-8569-6163
Chadia NahyInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.
Anne MaglottInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.
Bastien MorletInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.
Chao GaoDepartment of Neurology, Peking University First Hospital, Beijing, China.
Elise LefebvreInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.ORCID http://orcid.org/0009-0001-0444-4579
Muriel PhilippsInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.
Pascal EberlingInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.
Angélique PichotInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.
Paola RossolilloInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.
Christelle ThibaultInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.ORCID http://orcid.org/0000-0003-1562-1451
Mustapha Oulad-AbdelghaniInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France.
Ichizo NishinoDepartment of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.ORCID http://orcid.org/0000-0001-9452-112X
Kang YangDepartment of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China.
Ning WangDepartment of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China.ORCID http://orcid.org/0000-0002-9655-9735
Zhaoxia WangDepartment of Neurology, Peking University First Hospital, Beijing, China.
Jianwen DengDepartment of Neurology, Peking University First Hospital, Beijing, China. jianwendeng@pkufh.com.ORCID http://orcid.org/0000-0003-1206-1778
Nicolas Charlet-BerguerandInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS UMR 7104, Inserm UMR-S, Illkirch, France. ncharlet@igbmc.fr.ORCID http://orcid.org/0000-0002-4423-4920

Funding

Agence Nationale de la Recherche (French National Research Agency) EUR IMCBio (ANR-17-EURE-0023)Beijing Nova Program 20220484017Beijing Nova Program 20230484403Fondation pour la Recherche Médicale (Foundation for Medical Research in France) FRM EQU202103012936National Natural Science Foundation of China (National Science Foundation of China) 82071409National Natural Science Foundation of China (National Science Foundation of China) 82171846National Natural Science Foundation of China (National Science Foundation of China) 82401635National Natural Science Foundation of China (National Science Foundation of China) 82422025Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) 7244421
6 · The paper itself

Abstract

A total of 3-6% human genome is composed of microsatellite sequences, which are short DNA elements composed of two to six nucleotide motifs repeated in tandem. Expansion of a subset of these microsatellites is the leading cause of >60 diseases. However, most of these mutations are located in sequences annotated as noncoding, which raises questions about their pathogenicity. Here we found that GGC repeat expansions causing oculopharyngodistal myopathy with or without oculopharyngeal myopathy leukoencephalopathy are located within previously unrecognized open reading frames (ORFs), resulting in their translation into new polyglycine-containing proteins. Antibodies developed against these proteins stain the p62-positive inclusions typical of these diseases. Moreover, expression of these polyglycine proteins causes locomotor and skeletal muscle alterations associated with neurodegeneration in cell, fly and mouse models. Finally, we identified a compound, the cationic porphyrin TMPyP4, targeting the expression of these polyglycine proteins, raising hope to develop a therapy for these disorders. Overall, this work highlights the complexity and richness of the human genome and the importance of mutations in yet-unrecognized small ORFs.

Indexed as

Muscular Dystrophy, OculopharyngealOpen Reading FramesPeptidesTrinucleotide Repeat ExpansionAnimalsHumansMiceMuscle, SkeletalPeptidespolyglycine

Identifiers

PMID41703050
PMCPMC12987736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.